Genadieva-Stavrik, S., Boumendil, A., Dreger, P., Peggs, K., Briones, J., Corradini, P., . . . Sureda, A. (2016). Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Annals of oncology, 27(12), .
Chicago-Zitierstil (17. Ausg.)Genadieva-Stavrik, Sonja, et al. "Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation for Relapsed/refractory Hodgkin's Lymphoma in Recent Years: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation." Annals of Oncology 27, no. 12 (2016).
MLA-Zitierstil (9. Ausg.)Genadieva-Stavrik, Sonja, et al. "Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation for Relapsed/refractory Hodgkin's Lymphoma in Recent Years: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation." Annals of Oncology, vol. 27, no. 12, 2016.